Ignyta
San Diego
About Ignyta
Ignyta is a scientifically-driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goal is to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide. Ignyta was incorporated in 2011 and operates in San Diego, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $450.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Oct 2017)
- Ticker: nasdaq:RXDX
- Website: ignyta.com
- Phone: (858)255-5959
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/ignyta-173821 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.